We recently showed from a Swedish cohort that nearly half of boys born post-term (≥42 weeks gestation) were overweight or obese at 16 years of age. We hypothesized that post-term children would display features of insulin resistance and the metabolic syndrome even in their pre-pubertal years.
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We recently showed from a Swedish cohort that nearly half of boys born post-term (≥42 weeks gestation) were overweight or obese at 16 years of age. We hypothesized that post-term children would display features of insulin resistance and the metabolic syndrome even in their pre-pubertal years.
90 healthy pre-pubertal children aged 4-11 years, with birth weight appropriate-for-gestational-age were studied: 36 children born post-term (18 boys and 18 girls) and 54 children (36 boys and 18 girls) born at term (38-40 weeks). Insulin sensitivity was measured using Bergman's minimal model. Other assessments included fasting lipid and hormonal profiles, body composition using whole-body dual-energy x-ray absorptiometry, and 24-hour ambulatory blood pressure monitoring.
Insulin sensitivity was reduced in post-term children (8.44±0.74 vs 13.55±0.89 x10 -4 ·min −1 ·(mU/L); p<0.0001). Post-term children had an adverse lipid profile, with higher total cholesterol (4.26±0.17 vs 3.92±0.11 mmol/l; p=0.023) and LDL (2.51±0.13 vs 2.25±0.08 mmol/l; p=0.016) concentrations. Further changes suggestive of the metabolic syndrome among post-term children included an increased android to gynoid fat ratio (0.74 ±0.03 vs 0.61±0.02; p=0.026), and a reduction in the normal nocturnal systolic blood pressure dip (8.2±1.0 vs 13.8±1.0%; p=0.016). Post-term children also had higher serum leptin (7.18±0.91 vs 3.67±0.41 ng/ml; p=0.011), lower adiponectin (8226±693 vs 10536±556 ng/ml; p=0.046), and lower IGFBP1 (9.56±1.06 vs 18.03±1.59 ng/ml; p=0.032) concentrations.
Our study shows for the first time that post-term children have early features of the metabolic syndrome, including reduced insulin sensitivity, adverse lipid profile, and increased abdominal adiposity.
